Physician profile
Ronald Joseph Quam
NPI 1306908033
$6,558.36
in general payments reported to CMS, 2019-2025
14 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $471 · 2021: $131 · 2022: $733 · 2023: $3,106 · 2024: $247 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,494 · Travel and Lodging: $2,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,493.65 |
| Travel and Lodging | $2,358.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,221.72 | 2020-2025 | Real Intelligence, Legion, Redapt |
| Stryker Corporation | $1,373.54 | 2022-2025 | Gamma, Pangea, Variax |
| Zimmer Biomet Holdings, INC. | $1,037.76 | 2019-2025 | Persona, Gel-One Cross-Linked Hyaluronate, G7 |
| Linvatec Corporation | $267.25 | 2023-2024 | Biobrace 23mm, Livatec Knee Preservation System |
| Avanos Medical | $158.54 | 2023-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Pacira Pharmaceuticals Incorporated | $132.72 | 2019 | |
| Depuy Synthes Sales INC. | $122.39 | 2019 | |
| Acumed LLC | $55.50 | 2025 | Acumed |
| Medical Device Business Services, INC. | $44.33 | 2022 | |
| Abbott Laboratories | $33.69 | 2022 | |
| Ethicon US, LLC | $32.33 | 2021 | |
| Kci USA, INC. | $30.46 | 2020 | |
| Bioventus LLC | $28.13 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Orthalign INC | $20.00 | 2024 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Quam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.